Global & Finland IoT Medical Devices Market to 2033
Description
Germany stands at the forefront of IoT medical devices, propelled by its strong healthcare framework, a significant aging demographic, a high incidence of chronic illnesses, and a thorough digital health strategy. The Digitalisation Strategy for Health and Care 2023 outlines a clear vision for a resilient, future-ready healthcare system enhanced by digital technologies. Recent legislative measures have greatly influenced the digital health landscape. The eHealth Act and subsequent reforms have laid the groundwork for the Electronic Patient Record (ePA), which has been progressively rolled out since January 2021 and is expected to be accessible to all patients covered by statutory health insurance by 2025.
The Digital Act (Gesetz zur Beschleunigung der Digitalisierung des Gesundheitswesens), effective from March 2024, further encourages the incorporation of digital health applications (DiGA) into healthcare practices. DiGAs are CE-certified medical applications that can be prescribed by healthcare providers and reimbursed by statutory health insurance, with the system expanding to include Class IIb medical devices in 2024. This innovative reimbursement model serves as a significant driver for the adoption of IoT medical devices.
Telemedicine has experienced deregulation, with the legal framework for video consultations established in 2019, leading to a notable increase in usage, especially during the COVID-19 pandemic. This trend supports the implementation of IoT for remote patient monitoring. For example, German firms have created IoT solutions for the remote tracking of cough symptoms using sensor-based devices and AI algorithms, as well as electronic medical tablets designed for intensive care specialists to monitor patients remotely.
According to the Robert Koch Institute, Germany has 18.6 million individuals aged 65 and older, with 6.1 million over the age of 80. The high prevalence of chronic diseases, often linked to aging, fuels the demand for IoT solutions that enable continuous monitoring and management. For instance, hypertension affects nearly two-thirds of those aged 65 and above, while type 2 diabetes is anticipated to impact around 10 to 14 million individuals by 2040. Germany's strong focus on innovation, solid regulatory framework, and extensive digital infrastructure firmly position it as a leader in the IoT medical device sector.
The Digital Act (Gesetz zur Beschleunigung der Digitalisierung des Gesundheitswesens), effective from March 2024, further encourages the incorporation of digital health applications (DiGA) into healthcare practices. DiGAs are CE-certified medical applications that can be prescribed by healthcare providers and reimbursed by statutory health insurance, with the system expanding to include Class IIb medical devices in 2024. This innovative reimbursement model serves as a significant driver for the adoption of IoT medical devices.
Telemedicine has experienced deregulation, with the legal framework for video consultations established in 2019, leading to a notable increase in usage, especially during the COVID-19 pandemic. This trend supports the implementation of IoT for remote patient monitoring. For example, German firms have created IoT solutions for the remote tracking of cough symptoms using sensor-based devices and AI algorithms, as well as electronic medical tablets designed for intensive care specialists to monitor patients remotely.
According to the Robert Koch Institute, Germany has 18.6 million individuals aged 65 and older, with 6.1 million over the age of 80. The high prevalence of chronic diseases, often linked to aging, fuels the demand for IoT solutions that enable continuous monitoring and management. For instance, hypertension affects nearly two-thirds of those aged 65 and above, while type 2 diabetes is anticipated to impact around 10 to 14 million individuals by 2040. Germany's strong focus on innovation, solid regulatory framework, and extensive digital infrastructure firmly position it as a leader in the IoT medical device sector.
Table of Contents
128 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. Finland IoT Medical Devices Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. IoT Medical Devices Market Key Market Dynamics
- 5.1 IoT Medical Devices Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints
- 6. Finland IoT Medical Devices Market – Analysis
- 6.1 Finland IoT Medical Devices Market Revenue (US$ Million), 2022–2033
- 6.2 Finland IoT Medical Devices Market Revenue and Forecast Analysis
- 7. Finland IoT Medical Devices Market Analysis – by Product
- 7.1 Finland IoT Medical Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by Product
- 8. Finland IoT Medical Devices Market Analysis – by Technology
- 8.1 Finland IoT Medical Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by Technology
- 9. Finland IoT Medical Devices Market Analysis – by Application
- 9.1 Finland IoT Medical Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by Application
- 10. Finland IoT Medical Devices Market Analysis – by End User
- 10.1 Finland IoT Medical Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by End User
- 11. Competitive Landscape
- 11.1 Heat Map Analysis by Key Players
- 11.1 Company Positioning and Concentration
- 12. Industry Landscape
- 12.1 Overview
- 12.2 Market Initiative
- 12.2 Partnerships and Collaborations
- 12.2 Other Developments
- 13. Company Profiles
- 13.1 Medtronic Plc
- 13.1. 1 Key Facts
- 13.1. 2 Business Description
- 13.1. 3 Products and Services
- 13.1. 4 Financial Overview
- 13.1. 5 SWOT Analysis
- 13.1. 6 Key Developments
- 13.2 GE HealthCare Technologies Inc
- 13.2. 1 Key Facts
- 13.2. 2 Business Description
- 13.2. 3 Products and Services
- 13.2. 4 Financial Overview
- 13.2. 5 SWOT Analysis
- 13.2. 6 Key Developments
- 13.3 Koninklijke Philips NV
- 13.3. 1 Key Facts
- 13.3. 2 Business Description
- 13.3. 3 Products and Services
- 13.3. 4 Financial Overview
- 13.3. 5 SWOT Analysis
- 13.3. 6 Key Developments
- 13.4 Abbott Laboratories
- 13.4. 1 Key Facts
- 13.4. 2 Business Description
- 13.4. 3 Products and Services
- 13.4. 4 Financial Overview
- 13.4. 5 SWOT Analysis
- 13.4. 6 Key Developments
- 13.5 Boston Scientific Corp
- 13.5. 1 Key Facts
- 13.5. 2 Business Description
- 13.5. 3 Products and Services
- 13.5. 4 Financial Overview
- 13.5. 5 SWOT Analysis
- 13.5. 6 Key Developments
- 13.6 Omron Healthcare Inc
- 13.6. 1 Key Facts
- 13.6. 2 Business Description
- 13.6. 3 Products and Services
- 13.6. 4 Financial Overview
- 13.6. 5 SWOT Analysis
- 13.6. 6 Key Developments
- 13.7 Baxter International Inc
- 13.7. 1 Key Facts
- 13.7. 2 Business Description
- 13.7. 3 Products and Services
- 13.7. 4 Financial Overview
- 13.7. 5 SWOT Analysis
- 13.7. 6 Key Developments
- 13.8 Siemens Healthineers AG
- 13.8. 1 Key Facts
- 13.8. 2 Business Description
- 13.8. 3 Products and Services
- 13.8. 4 Financial Overview
- 13.8. 5 SWOT Analysis
- 13.8. 6 Key Developments
- 13.9 Johnson & Johnson
- 13.9. 1 Key Facts
- 13.9. 2 Business Description
- 13.9. 3 Products and Services
- 13.9. 4 Financial Overview
- 13.9. 5 SWOT Analysis
- 13.9. 6 Key Developments
- 13.10 Dragerwerk AG & Co KGaA
- 13.10. 1 Key Facts
- 13.10. 2 Business Description
- 13.10. 3 Products and Services
- 13.10. 4 Financial Overview
- 13.10. 5 SWOT Analysis
- 13.10. 6 Key Developments
- 14. Appendix
- 14.1 About Business Market Insights
- 14.2 List of Abbreviations
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
